We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Neuromuscular Stimulator Increases Microcirculatory Blood Flow

By HospiMedica International staff writers
Posted on 28 Dec 2021
Image: The discrete geko device increases venous return in the legs (Photo courtesy of Sky Medical)
Image: The discrete geko device increases venous return in the legs (Photo courtesy of Sky Medical)
A wearable device increases microcirculatory blood flow in the lower limbs of patients with venous insufficiency and/or ischemia.

The Sky Medical Technology (High Wycombe, United Kingdom) geko device is a disposable wristwatch size device worn just under the knee that is designed to gently stimulate the common peroneal nerve. Due to its proximity to the posterior/anterior bifurcation, the common fibular nerve, and the external and lateral popliteal nerves, it’s stimulation results in activation of the tibialis, peroneus longus, and lateral gastrocnemius muscles. The simultaneous contraction of these muscles compresses and efficiently evacuates blood in the deep veins of the calf.

Once switched on, and the appropriate stimulation level selected, the patient is made aware of the muscle contractions, but with no change to either heart rate or blood pressure. During treatment, the uncomfortable sensation recedes after a few minutes thanks to accommodation, awareness of the muscle contractions lessens, and patients can carry on with their normal daily routine, including going to sleep. The geko device needs to be removed if the patient needs to a shower or bathe.

“Through our central strategy in partnering with healthcare professionals to solve challenging medical problems, we identify and translate clinical needs into cutting-edge products and evidence-based protocols,” said Bernard Ross, CEO of Sky Medical Technology. “The new standards of care simplify treatments for clinicians and improve patient outcomes, and new care pathways are in development in neurology, orthopedics, renal, and peripheral vascular disease.”

Venous insufficiency and ischemia relate to reduced blood flow in the veins and arteries, most often resulting from incompetent valves. Venous insufficiency can lead to lower extremity edema, skin changes, and discomfort, but if left untreated, can progress to chronic venous insufficiency (CVI), which can lead to post-phlebitic syndrome and venous leg ulcers.

Related Links:
Sky Medical Technology

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Open Stapler
PROXIMATE Linear Cutter
New
Ureteral Dilatation Balloon
Dornier Equinox

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more